2022 |
Waller A, Bryant J, Bowman A, White BP, Willmott L, Pickles R, et al., 'Junior medical doctors' decision making when using advance care directives to guide treatment for people with dementia: a cross-sectional vignette study', BMC MEDICAL ETHICS, 23 (2022) [C1]
|
|
Nova |
2022 |
Bryant J, Waller A, Bowman A, Pickles R, Hullick C, Price E, et al., 'Junior Medical Officers' knowledge of advance care directives and substitute decision making for people without decision making capacity: a cross sectional survey', BMC MEDICAL ETHICS, 23 (2022) [C1]
|
|
Nova |
2022 |
Aung AK, Pickles R, Knight A, Shannon L-A, Bowers A, Donnelly S, et al., 'Research activities in general medicine: a scoping survey by the Internal Medicine Society of Australia and New Zealand.', Intern Med J, 52 1505-1512 (2022) [C1]
|
|
Nova |
2021 |
Bryant J, Waller A, Pickles R, Hullick C, Price E, White B, et al., 'Knowledge and confidence of junior medical doctors in discussing and documenting resuscitation plans: a cross-sectional survey.', Internal medicine journal, 51 2055-2060 (2021) [C1]
|
|
Nova |
2020 |
Knight A, 'Managing the overlap of asthma and chronic obstructive pulmonary disease', Australian Prescriber, 43 7-11 (2020) [C1]
Approximately 20% of patients with obstructive lung disease have features of both asthma and chronic obstructive pulmonary disease. These patients have a higher burden of disease ... [more]
Approximately 20% of patients with obstructive lung disease have features of both asthma and chronic obstructive pulmonary disease. These patients have a higher burden of disease and increased exacerbations compared to those with asthma or chronic obstructive pulmonary disease alone. Management should address dominant clinical features in each individual patient, and comorbidities should be considered. There are several interventions that are useful in the management of both asthma and chronic obstructive pulmonary disease. As inhaled corticosteroids are key to the management of asthma, they are recommended in patients with overlapping chronic obstructive pulmonary disease.
|
|
Nova |
2018 |
Knight A, Wilkin M, Boyce L, 'An audit of medication information in electronic discharge summaries for older patients discharged from medical wards at a regional hospital', Journal of Pharmacy Practice and Research, 48 76-79 (2018) [C1]
|
|
|
2018 |
Knight A, Wilkin M, Boyce L, 'An audit of medication information in electronic discharge summaries for older patients discharged from medical wards at a regional hospital', Journal of Pharmacy Practice and Research, 48 76-79 (2018) [C1]
|
|
Nova |
2016 |
'Comment: Farewell to print', Australian Prescriber, 39 (2016)
|
|
|
2014 |
Gunathilake R, Lowe D, Wills J, Knight A, Braude P, 'Implementation of a multicomponent intervention to optimise patient safety through improved oxygen prescription in a rural hospital', AUSTRALIAN JOURNAL OF RURAL HEALTH, 22 328-333 (2014) [C1]
|
|
|
2013 |
Gunathilake R, Boyce LE, Knight AT, 'Pregabalin-associated rhabdomyolysis', MEDICAL JOURNAL OF AUSTRALIA, 199 624-625 (2013) [C3]
|
|
Nova |
2013 |
Boyce LE, Knight AT, 'Audit of general practitioner medication lists for older patients at a regional hospital', Journal of Pharmacy Practice and Research, 43 105-108 (2013) [C1]
Background: Complete medication reconciliation is often difficult to achieve, particularly in the emergency department (ED). General practitioner (GP) medication lists may be used... [more]
Background: Complete medication reconciliation is often difficult to achieve, particularly in the emergency department (ED). General practitioner (GP) medication lists may be used by some doctors for charting medications. Aim: To determine the discrepancies in the medication history information between GP medication lists and the actual medication usage of older patients admitted via a regional ED. Method: A clinical audit was conducted over a 2-week period at a small regional hospital. Patients 65 years and over, taking 3 or more medications prior to admission, admitted via the ED and with a national inpatient medication chart (NIMC) prepared by a medical officer were identified. Eligible patients were provided with medication reconciliation by a pharmacist. Discrepancies between the medication history obtained by the pharmacist, the GP medication list and the NIMC were assessed. The clinical significance of the discrepancies were classified using a severity assessment code matrix. Results: 48 patients were eligible and 75% had 1 or more discrepancy in their GP medication list. Almost half of the discrepancies were related to non-current medications being recorded. Potential clinical significance of the discrepancies in 19% of patients was 'moderate' or 'major'. Conclusion: While a GP medication list is a useful tool in the medication reconciliation process, it is not a complete representation of the patient's medications prior to admission.
|
|
Nova |